Researchers have designed a smart drug that hunts down and breaks a little-known RNA that cancer cells depend on. The drug ...

Last year, researchers at the University of California, Riverside, developed a novel "molecular crowbar" strategy to degrade ...

ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer immunotherapies, today announced an exclusive in-licensing deal with Cue ...

AML is a devastating blood cancer with low survival rates, particularly for older patients who cannot tolerate aggressive chemotherapy. Flashpoint's approach offers the potential for a new precision ...

This monumental scientific achievement occurred within a context of intense international collaboration, rapid technical ...

Pluri entered strategic collaborations across Asia, Europe and the United States ('U.S.”) to transform food and agriculture production via its subsidiaries’ advanced cell expansion ...

Texas A&M student develops first 3D turkey gut model, offering new way to study blackhead disease and protect flocks from devastating losses.

Situated in the state-of-the-art Acıbadem Taksim Hospital, Clinicana offers one of the safest and most medically integrated ...

EMBL scientists have improved a protein analysis technique, significantly expanding its use and making it 100 times faster.

Acetylation of lysine residues in the tail domain of histone H3 is well characterized, but lysine residues in the histone globular domain are also acetylated. Histone modifications in globular domain ...

Operator: Thank you for standing by. This is the conference operator. Welcome to the Ballard Power Systems Third Quarter twenty twenty five Results Conference Call.

For a lot of people, routine can feel like the least exciting thing they could be doing. A structured play-by-play of the day ...